Navigation Links
Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain
Date:9/23/2011

result in overdose and death.Summary of Clinical StudyPatients evaluated in this randomized, double-blind, double-dummy active controlled, superiority study had moderate-to-severe low back pain for at least three months and were receiving treatment with opioid analgesics at doses between 30 to 80 mg of morphine sulfate or the equivalent at least four days per week for at least 30 days prior to the screening visit.  Sixty-two percent (62%) of patients were taking hydrocodone-containing medications; 21% were taking oxycodone-containing medications; and 12% of patients were taking propoxyphene-containing medications.  Prospective patients were excluded if they were currently using the fentanyl transdermal-system, extended-release hydromorphone, or more than 80 mg per day of oral morphine equivalent for pain control upon entry into the study.

The study employed an enriched design – allowing only patients who both tolerated and responded to Butrans during an open label run-in period to enter into the 12-week double-blind phase of the trial, mimicking the treatment of patients in a clinical practice setting.  

The efficacy and safety of Butrans 20 mcg/hour was assessed using Butrans 5 mcg/hour as the low-dose control group.  All patients wore either active or placebo patches (double-dummy technique).  The study was performed at 75 centers in the United States.

Of the 1160 patients that entered the open-label run-in period, 57% were able to titrate to and tolerate the adverse effects of Butrans 20 mcg/hour and were randomized into a 12-week double-blind treatment phase.  Twelve percent (12%) of patients discontinued due to an adverse event and 21% discontinued due to lack of a therapeutic effect during the open-label titration period. A total of 660 patients were randomized to the double-blind phase to receive Butrans 20 mcg/hour, Butrans 5 mcg/hour, or an active control, for 12 weeks.  During the double-blind t
'/>"/>

SOURCE Purdue Pharma L.P.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AIMs Program for Improving Echocardiography Appropriateness Yields Impressive Results
2. Misonix Reports Fourth Quarter and Year-End Fiscal 2011 Financial Results
3. Accuray Announces Results for Fourth Quarter and Fiscal Year 2011
4. Misonix Schedules Fourth Quarter and Year-End Fiscal 2011 Financial Results Conference Call; September 20, 2011 at 4:30 p.m. Eastern
5. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
6. Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Results
7. Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon
8. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
9. Champions Oncology Reports Fiscal 2012 First Quarter Financial Results
10. Innocoll Announces Top-line Results from its Phase 2 Clinical Trial Investigating XaraColl® for the Management of Post-operative Pain and Receives "Notice of Allowability" for XaraColl U.S. Patent Application
11. Positive Results From Avanafil Phase 3 Study in Diabetics Presented at the 47th EASD Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Research and Markets  has announced the addition of ... Global Forecast to 2019" report to their offering. ... equipment market is categorized on the basis of product ... expected to register the highest growth rate in the ... 2019). This high growth is attributed to the rising ...
(Date:10/25/2014)... 2014 Research and Markets ... the "Global and Chinese Hemodialysis Concentrates Industry ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , Global ... a professional and in-depth study on the current ... focus on the Chinese situation. The ...
(Date:10/25/2014)... , Oct. 24, 2014 In conjunction ... quarter 2014 financial results press release, you are invited ... broadcast live over the internet on Monday, November 3, ... Time). A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations."  If you ...
Breaking Medicine Technology:Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
... Ind., Feb. 24, 2011 Symmetry Medical Inc. (NYSE: ... orthopaedic device industry and other medical markets, announced fourth quarter and ... 2011.Fourth QuarterTotal Year (In millions, except per share data) , ... 96.0 , $ 76.4 , 26%$ 360.8 , $ 365.9 , ...
... Mass. and SYDNEY, Feb. 24, 2011 HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced revenues of $20.9 million for the fourth ... million in revenues for the fourth quarter of 2009, ...
Cached Medicine Technology:Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 2Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 3Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 4Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 5Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 6Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 7Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 8Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 9HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 2HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 3HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 4HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 5HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 6
(Date:10/25/2014)... Market Research Report on ... is a professional and in-depth market survey ... The report firstly reviews the basic information ... and manufacturing technology. The report then explores ... Diagnostics listing their product specification, capacity, Production ...
(Date:10/25/2014)... October 25, 2014 Mesothelioma researchers are ... to receive pemetrexed (Alimta), after his combination drug therapy ... full story , just posted on the Surviving Mesothelioma ... Tokushukai Medical Center in Japan suggests that “maintenance therapy” ... patients who cannot tolerate higher doses of cisplatin. ...
(Date:10/25/2014)... 24, 2014 (HealthDay News) -- Not getting the right ... colitis, a new study suggests. Those who sleep ... hours per night may be more prone to developing ... researchers report. The study authors concluded that duration and ... among patients with inflammatory bowel diseases. "Both short ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... spot increased risks for certain cancers, one might think that ... But a new study suggests that, at least with colon ... their genes doubled their risk of colon cancer were no ... "It didn,t make any difference, not at all," said ...
(Date:10/22/2014)... On October 22, CBS will air an ... both fictional and real. The Charles E Holman ... to advocacy and philanthropy in the battle against Morgellons ... to impart truth and clarity about this misunderstood and ... misconceptions about Morgellons Disease (MD) and most ...
Breaking Medicine News(10 mins):Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3
... fibers, researchers say, , THURSDAY, Aug. 20 (HealthDay News) ... condition that can impair fertility, requires no surgery and ... experts said the accuracy of the new approach, which ... be replicated, which the researchers also acknowledged. , Until ...
... ... in full swing. Texas and Southwestern Cattle Raisers Association (TSCRA) Insurance Services is helping its ... equipping them with important preventative care measures that will not only save them money, but ... ...
... ... 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD). , ... Horsham, PA, USA (Vocus) August 20, ... Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD). , , , , ...
... List of cities and times below. Team will travel in a Motor ... filming comedy commercials against "Obama,s Death Care," including costumes, props and images. ... Aug. 20 The following was released today by Randall Terry, Director, Operation ... see the rage expressed at ,town hall meetings., However, much of this ...
... , , WHITE PLAINS, N.Y. ... August is National Immunization Awareness Month, and while ... The "Sounds of Pertussis", a campaign from the March of Dimes ... educating adults about pertussis prevention, so that they can keep themselves ...
... , WASHINGTON, Aug. 20 The American Red Cross ... the beach along the U.S. East Coast this weekend as experts ... the shore. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) ... Three storm with winds blowing up to 125 mph, and experts ...
Cached Medicine News:Health News:New Way Found to Diagnose Endometriosis 2Health News:New Way Found to Diagnose Endometriosis 3Health News:TSCRA Insurance Services Shares Importance of Back-to-School Preventative Health Care 2Health News:TSCRA Insurance Services Shares Importance of Back-to-School Preventative Health Care 3Health News:DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 2Health News:Healthcare and Abortion: Randall Terry Leads Protests and Press Conferences in 10 Cities in Five States 2Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 2Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 3Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 4Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 5Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 6Health News:American Red Cross Provides Safety Tips for Rip Tides Caused by Hurricane Bill 2
... a comprehensive, authoritative drug reference to ... overdose management, Canadian drug names, OTC ... drug references and tools is included ... (ED, PRIMARY CARE PLUS, CRC, RN, ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
... the latest in scientific clinical trial activity ... knowledge resources from CenterWatch. This highly valuable ... monitor and stay abreast of medical breakthroughs ... Clinical Trials, Clinical Trial Results, Newly Approved ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: